A group of leaders in the Church of God in Christ have been accused in a lawsuit of defrauding a major pharmaceutical company out of more than $200 million in rebates for diabetes drugs.
In a complaint filed May 19 in the US District Court for the Southern District of Florida, lawyers for Eli Lilly and Company alleged that a cost-sharing program covering millions of members of COGIC, a Pentecostal denomination, was a “sham.”
Instead of helping church members get access to Trulicity and other diabetes medications manufactured by Lilly, the program’s leaders worked with wholesalers to resell the drugs while collecting millions in rebates, the lawsuit claims.
